Calculation
P/S | = | Share price1, 2, 3 | ÷ | Sales per share1 | Sales per share1 | = | Revenue1 (in millions) |
÷ | No. shares of common stock outstanding2 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 13, 2024 | 9.83 | = | 183.49 | ÷ | 18.66 | 18.66 | = | 8,544 | ÷ | 457,867,115 | |
Feb 14, 2023 | 9.86 | = | 171.90 | ÷ | 17.44 | 17.44 | = | 8,080 | ÷ | 463,386,716 | |
Feb 15, 2022 | 12.00 | = | 197.76 | ÷ | 16.48 | 16.48 | = | 7,776 | ÷ | 471,970,580 | |
Feb 16, 2021 | 11.84 | = | 166.32 | ÷ | 14.05 | 14.05 | = | 6,675 | ÷ | 475,166,373 | |
Feb 13, 2020 | 11.00 | = | 144.94 | ÷ | 13.18 | 13.18 | = | 6,260 | ÷ | 474,933,945 | |
Feb 14, 2019 | 7.03 | = | 85.54 | ÷ | 12.17 | 12.17 | = | 5,825 | ÷ | 478,771,915 | |
Feb 15, 2018 | 7.18 | = | 78.50 | ÷ | 10.94 | 10.94 | = | 5,307 | ÷ | 485,253,713 | |
Feb 16, 2017 | 5.31 | = | 52.78 | ÷ | 9.94 | 9.94 | = | 4,888 | ÷ | 491,964,064 | |
Feb 24, 2016 | 4.42 | = | 42.37 | ÷ | 9.58 | 9.58 | = | 4,765 | ÷ | 497,155,532 | |
Feb 27, 2015 | 4.82 | = | 46.09 | ÷ | 9.55 | 9.55 | = | 4,785 | ÷ | 500,787,817 | |
Mar 26, 2014 | 3.21 | = | 29.21 | ÷ | 9.11 | 9.11 | = | 4,561 | ÷ | 500,729,429 | |
Mar 28, 2013 | 3.85 | = | 33.40 | ÷ | 8.67 | 8.67 | = | 4,336 | ÷ | 500,000,000 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31).
1 US$
2 Data adjusted for splits and stock dividends.
3 Closing price as at the filing date of Zoetis Inc. Annual Report.
Comparison to Competitors
Zoetis Inc. | AbbVie Inc. | Amgen Inc. | Bristol-Myers Squibb Co. | Danaher Corp. | Eli Lilly & Co. | Gilead Sciences Inc. | Johnson & Johnson | Merck & Co. Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Feb 13, 2024 | 9.83 | 5.72 | 5.78 | 2.19 | 7.76 | 20.77 | 3.40 | 4.43 | 5.43 | 2.66 | 7.84 | 4.99 |
Feb 14, 2023 | 9.86 | 4.61 | 5.17 | 3.29 | 5.79 | 10.96 | 3.86 | 4.34 | 4.71 | 2.37 | 7.01 | 4.73 |
Feb 15, 2022 | 12.00 | 4.53 | 5.10 | 3.16 | 6.37 | 8.01 | 2.85 | 4.66 | 3.96 | 3.18 | 4.20 | 5.39 |
Feb 16, 2021 | 11.84 | 4.05 | 5.64 | 3.16 | 7.01 | 8.06 | 3.24 | 5.15 | 3.93 | 4.50 | 6.24 | 5.52 |
Feb 13, 2020 | 11.00 | 4.22 | 6.03 | 5.52 | 6.29 | 6.03 | 4.00 | 4.79 | 4.33 | 3.66 | 5.34 | 4.83 |
Feb 14, 2019 | 7.03 | 3.58 | 5.22 | 3.67 | 3.97 | 5.15 | 3.84 | 4.45 | 4.92 | 4.49 | 6.62 | 4.24 |
Feb 15, 2018 | 7.18 | 6.67 | 5.82 | 5.02 | 3.70 | 3.71 | 4.10 | 4.56 | 3.68 | 4.05 | 5.92 | 4.01 |
Feb 16, 2017 | 5.31 | 3.84 | 5.65 | 4.72 | 3.48 | 4.18 | 3.08 | 4.62 | 4.54 | 3.84 | 7.86 | 3.37 |
Feb 24, 2016 | 4.42 | 3.83 | 5.28 | 6.07 | 2.91 | 4.02 | 3.80 | 4.13 | 3.56 | 3.76 | 9.38 | 3.05 |
Feb 27, 2015 | 4.82 | 4.90 | 6.13 | 6.28 | 3.09 | 4.03 | 6.36 | 3.77 | 3.93 | 4.24 | 14.62 | 3.06 |
Mar 26, 2014 | 3.21 | 4.31 | 5.22 | 5.48 | 2.78 | 2.81 | 11.95 | 3.63 | 3.78 | 3.97 | 15.52 | 3.74 |
Mar 28, 2013 | 3.85 | 3.30 | 4.09 | 3.40 | 2.32 | 2.71 | 6.95 | 3.17 | 2.73 | 3.34 | 11.66 | 2.12 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31).
Comparison to Sector (Pharmaceuticals, Biotechnology & Life Sciences)
Zoetis Inc., P/S, long-term trends, comparison to sector (pharmaceuticals, biotechnology & life sciences)
Zoetis Inc. | Pharmaceuticals, Biotechnology & Life Sciences | |
---|---|---|
Feb 13, 2024 | 9.83 | 5.86 |
Feb 14, 2023 | 9.86 | 4.58 |
Feb 15, 2022 | 12.00 | 4.57 |
Feb 16, 2021 | 11.84 | 4.96 |
Feb 13, 2020 | 11.00 | 4.87 |
Feb 14, 2019 | 7.03 | 4.48 |
Feb 15, 2018 | 7.18 | 4.55 |
Feb 16, 2017 | 5.31 | 4.26 |
Feb 24, 2016 | 4.42 | 4.05 |
Feb 27, 2015 | 4.82 | 4.47 |
Mar 26, 2014 | 3.21 | 4.23 |
Mar 28, 2013 | 3.85 | 3.25 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31).
Comparison to Industry (Health Care)
Zoetis Inc. | Health Care | |
---|---|---|
Feb 13, 2024 | 9.83 | 2.33 |
Feb 14, 2023 | 9.86 | 33,385.46 |
Feb 15, 2022 | 12.00 | 2.32 |
Feb 16, 2021 | 11.84 | 2.26 |
Feb 13, 2020 | 11.00 | 2.17 |
Feb 14, 2019 | 7.03 | 2.35 |
Feb 15, 2018 | 7.18 | 2.33 |
Feb 16, 2017 | 5.31 | 2.14 |
Feb 24, 2016 | 4.42 | 2.11 |
Feb 27, 2015 | 4.82 | 2.39 |
Mar 26, 2014 | 3.21 | 2.18 |
Mar 28, 2013 | 3.85 | 1.74 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31).